FDA Inspection 1227972 - GlaxoSmithKline Vaccines Srl - January 26, 2024

Record Details

This FDA Inspection record concerns GlaxoSmithKline Vaccines Srl, with an inspection on January 26, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: GlaxoSmithKline Vaccines Srl
Inspection Date: January 26, 2024
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 9a596115-82ae-447f-a50f-dc896f8640f4

Violation Codes5

21 CFR 211.160(a)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.25(a)21 CFR 314.80(c)(1)(i)

Full citation text and observation details available on the Dashboard.